Mesothelin variant 1 is released from tumor cells as a diagnostic marker

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 1014-1020

  Hellstrom, Ingegerd ^a   Raycraft, John ^b   Kanan, Sandra ^a   Sardesai, Niranjan Y ^c   Verch, Thorsten ^c   Yang, Yi ^a   Hellstrom, Karl Erick ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CombiMatrix Corporation ^*  (United States)

^c FUJIREBIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESOTHELIN; MESOTHELIN 1; MESOTHELIN 2; MESOTHELIN 3; UNCLASSIFIED DRUG;

ARTICLE; ASCITES; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33744738551     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0334     Document Type: Article

References (29)

1. Bast RCJ, Siegal FP, Runowicz C, et al. Elevation of serum CA125 prior to diagnosis of an epithelial ovarian carcinoma. Gynecol Oncol 1985;22:115-20.
2. Einhorn N, Sjovall K, Knapp RC, et al. J. Prospective evaluation of serum CA125 levels for early detection of ovarian cancer. Obstet Gynecol 1992;80:14-8.
3. Jacobs IJ, Skates S, Davies AP, et al. Risk of diagnosis of ovarian cancer after raised serum CA125 concentration: a prospective cohort study. Br Med J 1996;313:1355-8.
4. Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium. Cancer Res 1992;52:181-6.
5. Chang K, Pastan I. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. Int J Cancer 1994;157:90-7.
6. Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A 1996;93:136-40.
7. Chowdhury PS, Viner JL, Beers R, Pastan I. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proc Natl Acad Sci U S A 1998;95:669-74.
8. Rump A, Morikawa Y, Tanaka M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem 2004;279:9190-8.
9. Kojima T, Oh-eda M, Hattori K, et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem 1995;270:21984-90.
10. Scholler N, Fu N, Yang Y, et al. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A 1999;96:11531-6.
11. Robinson BWS, Creaney J, Lake RL, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362:1612-6.
12. McIntosh MW, Drescher C, Karlan B, et al. Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol 2004;95:9-15.
13. Muminova ZE, Strong TV, Shaw DR. Characterization of human mesothelin transcripts in ovarian and pancreatic cancer. BMC Cancer 2004;4:19-29.
14. Hassan R, Bera TK, Pastan I. Mesothelin: a new target for immunotherapy. Clin Cancer Res 2004;10:8751-3.
15. Capon DJ, Chamow SM, Mordenti J, et al. Designing CD4 immunoadhesins for AIDS therapy. Nature 1989;337:525-31.
16. Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 2003;63:3695-700.
17. Hayden MS, Linsley PS, Gayle MA, et al. Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system. Ther Immunol 1994;1:3-15.
18. Urlaub G, Mitchell PJ, Kas E, et al. Effect of γ rays at the dihydrofolate reductase locus: deletions and inversions. Somat Cell Mol Genet 1986;12:555-66.
19. Hellstrom I, Goodman G, Pullman J, Yang Y, Hellstrom KE. Overexpression of HER-2 in ovarian carcinomas. Cancer Res 2001;61:2420-3.
20. Eng K, McCormick AL, Yates JI. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994;5:976-89.
21. Chittum HS, Lane WS, Carlson BA, et al. Rabbit β-globin is extended beyond its UGA stop codon by multiple suppressions and translational reading gaps. Biochemistry 1998;37:10866-70.
22. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-6.
23. Scott J, Selby M, Urdea M, Quiroga M, Bell GI, Rutter WJ. Isolation of nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 1983;302:538-40.
24. Betzholz C, Johnsson A, Heldin CH, et al. cDNA sequence and chromosomal localization of human platelet-derived groth factor A-chain and its expression in tumour cell lines. Nature 1986;320:695-9.
25. Watanabe T, Nakagawa T, Ikemizu J, Nagahama M, Murakami K, Nakayama K. Sequence requirements for precursor cleavage within the constitutive secretory pathway. J Biol Chem 1992;267:8270-4.
26. Watanabe T, Murakami K, Nakayama K. Positional and additive effects of basic amino acids on processing of precursor proteins ithin the constitutive secretory pathway. FEBS Lett 1993;320:215-8.
27. Levy WP, Rubinstein M, Shively J, et al. Amino acid sequence of a human leukocyte interferon. Proc Natl Acad Sci U S A 1981;78:6186-90.
28. Pan YC, Stern AS, Familletti PC, Khan FR, Chizzonite R. Structural characterization of human interferon-γ: heterogeneity of the carboxyl terminus. Eur J Biochem 1987;166:145-9.
29. Rinderknecht E, O'Connor BH, Rodriguez H. Natural human interferon-γ. Complete amino acid sequence and determination of sites of glycosylation. J Biol Chem 1984;259:6790-7.